MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced results from two prespecified analyses from the Phase 3 CLEAR (Cholesterol Lowering via Bempedoic Acid, an ...
This secondary data review template is an indicative template which can be customized based on the operational needs that are clarified in the assessment objectives and defined more clearly in the ...
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19) Clinical trials frequently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results